PATENT CLAIM ANALYSIS

Application Number: 16209051
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-11
Patent Classification: ["424", "465000"]

Abstract:
An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in an elementary osmotic pump delivery system and at least one release enhancing agent.

Claim (Index 23):
The method of  claim 19 , wherein the (a) osmotically-active drug core further comprises at least one release-enhancing agent.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.2
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14881374', '15162829', '11412100', '10655725', '14261709']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.760867130426942
- 35 USC 102 Novelty (BERT): 0.5355915140240566
- Combined Prediction Score: 0.7383395687866534
- Mean Citation Score: 297.56756600000006
- Max Citation Score: 371.39285
- Similarity Product: 233.5544385120124

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test